Agios Pharmaceuticals Inc (AGIO)

Healthcare Pharmaceuticals & Medical Research Biotechnology & Medical Research

Track

Stock chart

Ticker: AGIO Exchange: NSM

Subscribe to get access to the transaction volume chart and in-chart transaction details

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Earnings

Earnings

Value bought

Past 90 days

Value sold

Past 90 days

Net insiders buying

Past 90 days

Trades (buy and sell)

Past 90 days

Company data

Subscribe to get access to the company description and key fundamental data (market cap, shares outstanding, dividend yield, % of shares held by insiders and more)

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PS: Planned sale, O: Option / Other

Notification date	Transaction date	B/S Transaction type	Insider and/or position	Nb. shares Price Value	Number of shares	Price	Value
2025-04-10	2025-04-10	PS Planned sale	FOUSE JACQUALYN A Non-Executive Director	1,000 -4.8% 25.90 USD 194,172	1,000 -4.8%	25.90	USD 100,000
2025-03-04	2025-03-03	PS Planned sale	Milanova Tsveta Chief Commercial Officer Officer	1,681 -6.8% 35.54 USD 59,743	1,681 -6.8%	35.54	USD 59,743
2025-03-04	2025-03-03	PS Planned sale	Burns James William Chief Legal Officer Officer	1,681 -6.2% 35.54 USD 59,743	1,681 -6.2%	35.54	USD 59,743
2025-03-04	2025-03-03	PS Planned sale	Burns James William Chief Legal Officer Officer	1,187 -5.2% 35.54 USD 42,186	1,187 -5.2%	35.54	USD 42,186
2025-03-04	2025-03-03	PS Planned sale	Burns James William Chief Legal Officer Officer	1,137 -5.7% 35.54 USD 40,409	1,137 -5.7%	35.54	USD 40,409
2025-03-04	2025-03-03	PS Planned sale	Jones Cecilia Chief Financial Officer Officer	1,681 -6.1% 35.54 USD 59,743	1,681 -6.1%	35.54	USD 59,743
2025-03-04	2025-03-03	PS Planned sale	Jones Cecilia Chief Financial Officer Officer	594 -2.6% 35.54 USD 21,111	594 -2.6%	35.54	USD 21,111
2025-03-04	2025-03-03	PS Planned sale	Goff Brian Chief Executive Officer Executive Director	8,794 -8.7% 35.54 USD 312,539	8,794 -8.7%	35.54	USD 312,539
2025-03-04	2025-03-03	PS Planned sale	Goff Brian Chief Executive Officer Executive Director	4,153 -4.8% 35.54 USD 147,598	4,153 -4.8%	35.54	USD 147,598
2025-03-04	2025-03-03	PS Planned sale	Gheuens Sarah Chief Medical Officer Officer	1,681 -3.0% 35.54 USD 59,743	1,681 -3.0%	35.54	USD 59,743
2025-03-04	2025-03-03	PS Planned sale	Gheuens Sarah Chief Medical Officer Officer	1,187 -2.3% 35.54 USD 42,186	1,187 -2.3%	35.54	USD 42,186
2025-03-04	2025-03-03	PS Planned sale	Gheuens Sarah Chief Medical Officer Officer	1,137 -2.4% 35.54 USD 40,409	1,137 -2.4%	35.54	USD 40,409
2025-03-04	2025-03-03	PS Planned sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	727 -7.2% 35.54 USD 25,838	727 -7.2%	35.54	USD 25,838
2025-03-04	2025-03-03	PS Planned sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	697 -8.3% 35.54 USD 24,771	697 -8.3%	35.54	USD 24,771
2025-03-04	2025-03-03	PS Planned sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	231 -3.7% 35.54 USD 8,210	231 -3.7%	35.54	USD 8,210
2025-02-05	2025-02-05	PS Planned sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	2,272 -29.5% 34.39 USD 78,134	2,272 -29.5%	34.39	USD 78,134
2025-01-07	2025-01-06	PS Planned sale	Milanova Tsveta Chief Commercial Officer Officer	2,804 -12.9% 32.18 USD 90,233	2,804 -12.9%	32.18	USD 90,233
2024-12-13	2024-12-11	PS Planned sale	Scadden David Non-Executive Director	200 -1.3% 46.28 USD 9,256	200 -1.3%	46.28	USD 9,256
2024-11-13	2024-11-08	PS Planned sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	772 -48.7% 56.09 USD 43,301	772 -48.7%	56.09	USD 43,301
2024-11-12	2024-11-08	PS Planned sale	Ballal Rahul D. Non-Executive Director	1,500 -15.8% 59.21 USD 88,815	1,500 -15.8%	59.21	USD 88,815
2024-11-12	2024-11-08	PS Planned sale	Ballal Rahul D. Non-Executive Director	4,929 -34.2% 58.57 USD 288,692	4,929 -34.2%	58.57	USD 288,692
2024-11-12	2024-11-08	PS Planned sale	Ballal Rahul D. Non-Executive Director	3,571 -19.8% 57.24 USD 204,404	3,571 -19.8%	57.24	USD 204,404
2024-11-12	2024-11-07	PS Planned sale	Ballal Rahul D. Non-Executive Director	1,868 -18.9% 54.41 USD 101,638	1,868 -18.9%	54.41	USD 101,638
2024-11-12	2024-11-07	PS Planned sale	Ballal Rahul D. Non-Executive Director	8,132 -45.2% 53.32 USD 433,598	8,132 -45.2%	53.32	USD 433,598
2024-11-12	2024-11-07	PS Planned sale	Burns James William Chief Legal Officer Officer	8,341 -34.7% 52.56 USD 438,403	8,341 -34.7%	52.56	USD 438,403
2024-11-12	2024-11-07	PS Planned sale	Burns James William Chief Legal Officer Officer	13,411 -35.8% 52.00 USD 697,372	13,411 -35.8%	52.00	USD 697,372
2024-09-30	2024-09-26	PS Planned sale	Jones Cecilia Chief Financial Officer Officer	2,542 -11.2% 49.03 USD 124,634	2,542 -11.2%	49.03	USD 124,634
2024-08-12	2024-08-08	PS Planned sale	Goff Brian Chief Executive Officer Executive Director	11,091 -12.3% 42.75 USD 474,140	11,091 -12.3%	42.75	USD 474,140
2024-07-03	2024-07-01	PS Planned sale	Gheuens Sarah Chief Medical Officer Officer	3,705 -7.8% 43.85 USD 162,464	3,705 -7.8%	43.85	USD 162,464
2024-06-07	2024-06-05	PS Planned sale	Goff Brian Chief Executive Officer Executive Director	12,115 -15.3% 48.84 USD 591,697	12,115 -15.3%	48.84	USD 591,697
2024-06-05	2024-06-03	S Sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	1,362 -47.2% 44.39 USD 60,459	1,362 -47.2%	44.39	USD 60,459
2024-04-10	2024-04-10	PS Planned sale	FOUSE JACQUALYN A Non-Executive Director	7,791 -5.4% 27.55 USD 214,642	7,791 -5.4%	27.55	USD 214,642
2024-03-11	2024-03-07	S Sale	Foster-Cheek Kaye I Non-Executive Director	1,285 -18.9% 31.62 USD 40,632	1,285 -18.9%	31.62	USD 40,632
2024-03-07	2024-03-06	S Sale	Foster-Cheek Kaye I Non-Executive Director	4,415 -39.3% 31.99 USD 141,236	4,415 -39.3%	31.99	USD 141,236
2024-03-07	2024-03-05	S Sale	Foster-Cheek Kaye I Non-Executive Director	300 -2.6% 32.21 USD 9,663	300 -2.6%	32.21	USD 9,663
2024-03-07	2024-03-05	S Sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	1,913 -39.9% 31.75 USD 60,738	1,913 -39.9%	31.75	USD 60,738
2024-03-05	2024-03-05	PS Planned sale	Jones Cecilia Chief Financial Officer Officer	672 -4.3% 32.57 USD 21,887	672 -4.3%	32.57	USD 21,887
2024-03-05	2024-03-05	PS Planned sale	Goff Brian Chief Executive Officer Executive Director	4,156 -7.2% 32.57 USD 135,361	4,156 -7.2%	32.57	USD 135,361
2024-03-05	2024-03-05	PS Planned sale	Gheuens Sarah Chief Medical Officer Officer	1,349 -3.3% 32.57 USD 43,937	1,349 -3.3%	32.57	USD 43,937
2024-03-05	2024-03-05	PS Planned sale	Gheuens Sarah Chief Medical Officer Officer	1,293 -3.4% 32.57 USD 42,113	1,293 -3.4%	32.57	USD 42,113
2024-03-05	2024-03-05	PS Planned sale	Burns James William Chief Legal Officer Officer	1,349 -3.5% 32.57 USD 43,937	1,349 -3.5%	32.57	USD 43,937
2024-03-05	2024-03-05	PS Planned sale	Burns James William Chief Legal Officer Officer	1,293 -3.6% 32.57 USD 42,113	1,293 -3.6%	32.57	USD 42,113
2024-03-05	2024-03-05	PS Planned sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	919 -16.1% 32.57 USD 29,932	919 -16.1%	32.57	USD 29,932
2024-03-05	2024-03-05	PS Planned sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	295 -8.1% 32.57 USD 9,608	295 -8.1%	32.57	USD 9,608
2024-02-29	2024-02-27	S Sale	Schenkein David P Non-Executive Director	57,471 -31.9% 34.89 USD 2,005,163	57,471 -31.9%	34.89	USD 2,005,163
2024-02-29	2024-02-27	S Sale	Schenkein David P Non-Executive Director	11,858 -8.8% 33.60 USD 398,429	11,858 -8.8%	33.60	USD 398,429
2024-02-27	2024-02-26	S Sale	Schenkein David P Non-Executive Director	20,411 -14.2% 33.19 USD 677,441	20,411 -14.2%	33.19	USD 677,441
2024-02-27	2024-02-23	S Sale	Schenkein David P Non-Executive Director	47,731 -28.0% 33.05 USD 1,577,510	47,731 -28.0%	33.05	USD 1,577,510
2024-02-22	2024-02-20	S Sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	504 -15.5% 26.63 USD 13,422	504 -15.5%	26.63	USD 13,422
2024-02-14	2024-02-14	PS Planned sale	Burns James William Chief Legal Officer Officer	545 -1.7% 25.14 USD 13,701	545 -1.7%	25.14	USD 13,701
2024-02-14	2024-02-14	PS Planned sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	273 -7.8% 25.14 USD 6,863	273 -7.8%	25.14	USD 6,863
2024-02-14	2024-02-14	PS Planned sale	Gheuens Sarah Chief Medical Officer Officer	642 -1.9% 25.14 USD 16,140	642 -1.9%	25.14	USD 16,140
2024-01-24	2024-01-24	PS Planned sale	Goff Brian Chief Executive Officer Executive Director	7,635 -13.4% 21.64 USD 165,221	7,635 -13.4%	21.64	USD 165,221
2024-01-24	2024-01-24	PS Planned sale	Jones Cecilia Chief Financial Officer Officer	1,886 -12.6% 21.64 USD 40,813	1,886 -12.6%	21.64	USD 40,813
2024-01-24	2024-01-24	PS Planned sale	FOUSE JACQUALYN A Non-Executive Director	10,722 -7.7% 21.64 USD 232,024	10,722 -7.7%	21.64	USD 232,024
2024-01-24	2024-01-24	PS Planned sale	Gheuens Sarah Chief Medical Officer Officer	1,708 -5.1% 21.64 USD 36,961	1,708 -5.1%	21.64	USD 36,961
2024-01-24	2024-01-24	PS Planned sale	Burns James William Chief Legal Officer Officer	1,708 -5.3% 21.64 USD 36,961	1,708 -5.3%	21.64	USD 36,961
2024-01-24	2024-01-24	PS Planned sale	Milanova Tsveta Chief Commercial Officer Officer	1,618 -10.9% 21.64 USD 35,014	1,618 -10.9%	21.64	USD 35,014
2024-01-09	2024-01-09	PS Planned sale	FOUSE JACQUALYN A Non-Executive Director	8,391 -6.7% 22.99 USD 192,909	8,391 -6.7%	22.99	USD 192,909
2024-01-09	2024-01-09	PS Planned sale	Goff Brian Chief Executive Officer Executive Director	12,066 -23.2% 22.99 USD 277,397	12,066 -23.2%	22.99	USD 277,397
2024-01-09	2024-01-09	PS Planned sale	Burns James William Chief Legal Officer Officer	1,163 -4.2% 22.99 USD 26,737	1,163 -4.2%	22.99	USD 26,737
2024-01-09	2024-01-09	PS Planned sale	Gheuens Sarah Chief Medical Officer Officer	1,789 -6.0% 22.99 USD 41,129	1,789 -6.0%	22.99	USD 41,129
2024-01-05	2024-01-05	PS Planned sale	Milanova Tsveta Chief Commercial Officer Officer	2,902 -23.6% 22.32 USD 64,773	2,902 -23.6%	22.32	USD 64,773
2023-09-28	2023-09-28	PS Planned sale	Jones Cecilia Chief Financial Officer Officer	2,179 -18.5% 24.79 USD 54,017	2,179 -18.5%	24.79	USD 54,017
2023-08-21	2023-08-17	S Sale	Burns James William Chief Legal Officer Officer	6,395 -21.1% 26.28 USD 168,061	6,395 -21.1%	26.28	USD 168,061
2023-08-11	2023-08-09	S Sale	Foster-Cheek Kaye I Non-Executive Director	25,000 -68.4% 25.96 USD 648,888	25,000 -68.4%	25.96	USD 648,888
2023-08-10	2023-08-08	S Sale	Goff Brian Chief Executive Officer Executive Director	10,178 -27.7% 25.48 USD 259,335	10,178 -27.7%	25.48	USD 259,335
2023-08-09	2023-08-07	S Sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	2,918 -51.6% 25.39 USD 74,096	2,918 -51.6%	25.39	USD 74,096
2023-08-02	2023-08-01	S Sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	1,232 -17.9% 26.26 USD 32,352	1,232 -17.9%	26.26	USD 32,352
2023-04-05	2023-04-03	PS Planned sale	Schenkein David P Non-Executive Director	16,363 -12.2% 22.85 USD 373,895	16,363 -12.2%	22.85	USD 373,895
2023-03-29	2023-03-27	PS Planned sale	Schenkein David P Non-Executive Director	20,000 -14.5% 22.15 USD 443,000	20,000 -14.5%	22.15	USD 443,000
2023-03-15	2023-03-13	PS Planned sale	Schenkein David P Non-Executive Director	1,667 -1.4% 22.72 USD 37,874	1,667 -1.4%	22.72	USD 37,874
2023-03-15	2023-03-13	PS Planned sale	Schenkein David P Non-Executive Director	18,333 -13.3% 22.47 USD 411,943	18,333 -13.3%	22.47	USD 411,943
2023-03-07	2023-03-03	PS Planned sale	Washburn Theodore James Jr. Principal Accounting Officer Officer	504 -15.5% 24.29 USD 12,242	504 -15.5%	24.29	USD 12,242
2023-03-01	2023-02-27	PS Planned sale	Schenkein David P Non-Executive Director	20,000 -14.5% 25.37 USD 507,400	20,000 -14.5%	25.37	USD 507,400

Agios Pharmaceuticals Inc (AGIO)

Track

Stock chart

Earnings

Value bought

Value sold

Net insiders buying

Trades (buy and sell)

Transactions

Insider

Sort by